Enlivex Therapeutics Ltd

NASDAQ:ENLV   4:00:00 PM EDT
1.32
-0.08 (-5.71%)
5:33:17 PM EDT: $1.33 +0.01 (+0.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Enlivex Therapeutics Ltd Stock, NASDAQ:ENLV

14 Einstein Street, 14 Einstein Street, Ness Ziona, Tel Aviv 7403618
Israel
Phone: +972.8.662.3301
Number of Employees:
http://www.enlivex.com

Description

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.